Skip to main content
TipRanks
Go Ultimate75% OFF

Diversified Healthcare Trust (DHC) Q3 2026 Earnings Report

626 Followers

DHC Q3 2026 EPS Results

Actual EPS
$0.13
Consensus EPS
-$0.15
Beat/Miss
Beat by +$0.28
One Year Ago EPS
$0.04

DHC Q3 2026 Revenue Results

Actual Revenue
$367.67M
Expected Revenue
$370.87M
Beat/Miss
Missed by -$3.20M
YoY Revenue Growth
-5.41%

Earnings Announcement Details

Quarter
Q3 2026
Date
11/02/2026
Time
After Close
Conference Call
Monday, November 2, 2026
DHC Upcoming Earnings

Diversified Healthcare Trust's next earnings date is estimated for March 1, 2027, based on past reporting schedules.

Q3 2026 Earnings Call Audio

DHC Q3 2026 Earnings Call
0:00 / 0:00

Q3 2026 Earnings Slide Deck

Q3 2026 Earnings Call Summary

Q3 2026
Earnings Call Date:Nov 02, 2026|% Change Since:-6.46%|
Earnings Call Sentiment|Positive

The call was predominantly positive, led by strong year-over-year growth in Adjusted EBITDAre, consolidated NOI, and SHOP NOI; improved occupancy and margins; raised SHOP NOI guidance; lower recurring capital expenditure guidance; portfolio optimization initiatives; and improving liquidity and credit metrics. The main challenges were medical office and life science vacancies, a sequential SHOP NOI decline caused by stated one-time and seasonal items, temporary use of occupancy concessions, and lower normalized FFO per-share guidance due to the revised incentive fee presentation.

Company Guidance

For full year 2026, same property SHOP NOI guidance was raised by $5 million at the midpoint to $190 million to $200 million, with expected operating expense growth of 2.3% compared with 2.5% previously, average monthly rate growth of 5.6% up from 5.5%, occupancy growth unchanged at 200 basis points, and revenue growth of 6.3%; updated guidance is $312 million to $328 million of same property NOI, Adjusted EBITDAre of $276 million to $291 million, normalized FFO of $111 million to $126 million or $0.46 to $0.52 per share, and recurring capital expenditures of $90 million to $105 million, a reduction of $10 million at the midpoint, with estimated incentive management fees of $29.3 million or $0.12 per share included; fourth quarter results will include a full quarter of Ensign rent contributing approximately $2 million of cash NOI, recurring SHOP CapEx could decrease a little bit into 2027 and 2028 with a target closer to $3 thousand per unit, and redevelopment projects are all 2027 starts, with the swinging of hammers expected to commence next year and some projects beginning toward the back half of the year.

  • Strong Third-Quarter Financial PerformanceNormalized FFO was $30.7 million, or $0.13 per share, and Adjusted EBITDAre was $73.4 million, an increase of 28.4% year over year. On the comparable basis including estimated incentive management fees, normalized FFO increased from $0.02 per share a year ago and from $0.12 per share in the second quarter.
  • Broad-Based NOI GrowthConsolidated same property cash basis NOI increased 25.6% year over year to $77.9 million, while consolidated NOI increased 27.5% to $80.8 million.
  • SHOP Operating MomentumSame property SHOP NOI increased 50.4% year over year to $48 million. Occupancy increased 200 basis points to 84.4%, average monthly rate increased 5.2%, and same property SHOP NOI margin expanded 470 basis points to 15.8%. Same property SHOP revenue increased 5.8% year over year, while same property operating expenses were essentially flat.
  • SHOP Expense Savings and Occupancy OpportunityDietary procurement initiatives contributed to an expense reduction of approximately $1.3 million compared with the prior year, and expense per occupied unit declined 30 basis points. Management estimated 500 to 600 basis points of occupancy opportunity as operators close gaps between DHC communities and their respective NIC markets.
  • SHOP Guidance RaisedFull-year same property SHOP NOI guidance was increased by $5 million at the midpoint to $190 million to $200 million. The updated outlook reflects expected operating expense growth of 2.3% versus 2.5% previously, average monthly rate growth of 5.6% versus 5.5% previously, occupancy growth unchanged at 200 basis points, and revenue growth of 6.3%.
  • Recurring Capital Expenditure Guidance ReducedFull-year 2026 recurring capital expenditure guidance was reduced by $10 million at the midpoint to $90 million to $105 million. Year-to-date capital spending was $76.5 million, down $32.1 million, or approximately 30%, from the same period in 2025.
  • Skilled Nursing Conversion ProjectsDHC is repositioning underutilized and closed skilled nursing wings into independent living, assisted living, and memory care across 13 communities. The projects are expected to add approximately 356 units and generate stabilized cash returns in the mid teens or better. The projects are expected to begin in 2027, with current-year spending limited to soft costs related to design and consultants.
  • New SHOP Management AgreementsDHC is putting new management agreements in place across 76 SHOP communities managed by legacy operators, with implementation expected on January 1, 2027. The agreements are expected to initially generate approximately $2 million of annual cost savings and include more closely aligned incentive structures and appropriately sized base management fees.
  • Ensign Triple-Net Lease TransitionSeven Colorado nursing facilities were transitioned to a 15-year triple-net lease with Ensign effective October 1. First-year contractual rent is approximately $8 million with CPI annual escalators, compared with $5.1 million of NOI during the prior 12 months, or approximately $3.5 million after capital expenditures. The structure shifts reimbursement, labor, and capital exposure to the tenant and would have lifted third-quarter consolidated SHOP margin by about 80 basis points on a pro forma basis.
  • Additional Operator Transition in GeorgiaDHC provided notice in September to transition six SHOP communities in Georgia, representing 486 units, to a new manager. The transition is expected to begin as early as the fourth quarter and will consolidate the communities with an operator described as having deep regional expertise.
  • Medical Office and Life Science Leasing ActivityDHC completed approximately 130,000 square feet of leasing during the quarter at rental rates 25% above prior rents, with a weighted average lease term of 9.7 years. Near-term expirations are limited, with $3.3 million of annualized rental income, or 2.1% of total rental income, scheduled to expire through year end.
  • Disposition and Capital Recycling OpportunitiesDHC is under agreement to sell one vacant 120,000-square-foot property for $10.5 million and is evaluating offers on additional properties totaling approximately 232,000 square feet. The three properties generated negative NOI of $690,000 during the quarter, or nearly $2.8 million annually, and management stated that selling them would eliminate that drag and provide capital for reinvestment.
  • Improved Liquidity and Credit MetricsQuarter-end total liquidity was $261 million, including $111 million of cash and an undrawn $150 million secured revolving credit facility. Net debt to annualized Adjusted EBITDAre was 8.2x, a 2.5x reduction from a year ago; excluding incentive fees, leverage was 7.4x, within the 6.5x to 7.5x target range. Adjusted EBITDAre to interest expense improved to 2.0x from 1.2x a year ago, and DHC remained in compliance with all bond covenants.
  • Long-Term Shareholder ReturnManagement stated that DHC had been the top-performing REIT in the U.S. over the past three years, with total shareholder return in excess of 277%.
  • Updated Full-Year Outlook and 2027 DriversUpdated full-year guidance includes same property NOI of $312 million to $328 million, Adjusted EBITDAre of $276 million to $291 million, normalized FFO of $111 million to $126 million, or $0.46 to $0.52 per share, and recurring capital expenditures of $90 million to $105 million. Management identified 2027 drivers including a full year of Ensign rent, approximately $2 million of annual savings from the new SHOP legacy management agreements, skilled nursing conversion projects adding approximately 350 units, and the sale of non-earning medical office properties.

DHC Earnings History

DHC earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 01, 20272026 (Q4)-0.14--0.09――
Nov 02, 20262026 (Q3)-0.150.130.04193.02% (+0.08)
Aug 03, 20262026 (Q2)-0.15-0.160.08-302.53% (-0.24)
May 04, 20262026 (Q1)-0.16-0.180.06-415.79% (-0.24)
Feb 24, 20262025 (Q4)-0.17-0.09-0.3675.00% (+0.27)
Nov 03, 20252025 (Q3)-0.210.04-0.41110.49% (+0.45)
Aug 04, 20252025 (Q2)-0.220.08-0.41119.27% (+0.49)
May 05, 20252025 (Q1)-0.250.06-0.36115.83% (+0.42)
Feb 25, 20252024 (Q4)-0.29-0.36-0.4316.28% (+0.07)
Nov 04, 20242024 (Q3)-0.26-0.41-0.26-55.30% (-0.15)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed